Lipid-based nanosystems and complexes in experimental and clinical therapeutics

Keyphrases

• Angiogenic Tumors 33%
• Biological Systems 33%
• Biomimetic Properties 33%
• Cancer Tissue 33%
• Cationic Lipids 33%
• Cellular Toxicity 33%
• Clearance Mechanism 33%
• Clinical Treatment 100%
• Combination Chemotherapy 33%
• Complement Activation 33%
• Complex Nanostructures 33%
• Complexity System 33%
• Delivery System 33%
• Delivery Vehicle 33%
• Diagnostic Properties 33%
• Disease Diagnosis 33%
• Disease Treatment 33%
• Drug Delivery 33%
• Drug Delivery System 33%
• Drug Release Properties 33%
• Drug Side Effects 33%
• Drug Solubility 33%
• Drug Treatment 33%
• Endogenous Lipids 33%
• Endolysosomal 33%
• Europe 33%
• European Commission 33%
• European Science Foundation 33%
• Experimental Therapeutics 100%
• Feature Contribution 33%
• Forward Look 33%
• Fullerene C60 33%
• Gene Transfer 33%
• Immune Response 33%
• In Cancer 33%
• Lipid Complex 33%
• Lipid Micelles 33%
• Lipid Nanocarriers 33%
• Lipid Vectors 33%
• Lipid-based Delivery 33%
• Lipid-based Nanoformulation 33%
• Lipid-based Nanomedicines 33%
• Lipid-based Nanosystems 100%
• Lipids 33%
• Lipoproteins 33%
• Macrophage Clearance 33%
• Macrophage Infection 33%
• Malonic Acid Derivative 33%
• Microarray Technology 33%
• Modulatory 33%
• Nanobiotechnology 33%
• Nanocarriers 33%
• Nanodevices 33%
• Nanoemulsion 33%
• Nanomedicine 100%
• Nanoparticulate System 66%
• Nanoscience 100%
• Nanostructures 33%
• Nanosystems 33%
• Nanotechnology 33%
• National Cancer Institute 33%
• Network of Excellence 33%
• Non-allergic 33%
• Parenteral Administration 33%
• Particle Design 33%
• Pharmacokinetic Profile 33%
• Porous Titanium Oxide 33%
• Prodrug 33%
• Pseudo-allergic Reactions 33%
• Quantum Dots 33%
• Self-adjuvanting 33%
• Site-specific Delivery 33%
• Site-specific Targeting 100%
• Small Unilamellar Vesicles 33%
• Smart Nanoparticles 33%
• Specific Drug Targeting 33%
• Stability Issues 33%
• Superoxide Dismutase Mimetic 33%
• Sustained Drug Release 33%
• Technological Innovation 33%
• Toxicity Issues 66%
• Toxicogenomics 33%
• Tris 33%
• Tumor Vasculature 33%
• U.S. National Institutes of Health 33%
• Vesicular Systems 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 25%
• Clearance Mechanism 25%
• Combination Therapy 25%
• Drug Delivery System 50%
• Drug Release 25%
• Drug Solubility 25%
• Fullerene 25%
• Gene Delivery 25%
• Infection 25%
• Lipoprotein 25%
• Malignant Neoplasm 50%
• Malonic Acid Derivative 25%
• Micelle 25%
• Nanocarrier 50%
• Nanoemulsion 25%
• Nanomaterial 50%
• Nanomedicine 100%
• Nanoparticle 25%
• Pharmacokinetics 25%
• Pharmacotherapy 25%
• Prodrug 25%
• Quantum Dot 25%
• Side Effect 25%
• Superoxide Dismutase 25%
• Titanium Dioxide 25%
• Toxicogenomics 25%
• Trometamol 25%
• Tumor Vascularization 25%